Trial site
Universitaetsklinikum Wuerzburg AöR
- 223running trials
- 62closed trials
The trials here
What the 287 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma48 trials
- Childhood cancers34 trials
- Lung cancer33 trials
- Melanoma18 trials
- Acute lymphoblastic leukaemia11 trials
- Colorectal cancer10 trials
- Pancreatic cancer10 trials
- Follicular lymphoma9 trials
- Hidradenitis suppurativa9 trials
- Hodgkin lymphoma8 trials
- Prostate cancer8 trials
- Head and neck cancer7 trials
- and 64 more
- Phase
- Phase 3154 trials
- Phase 270 trials
- Phase 1/223 trials
- Phase 121 trials
- Phase 2/315 trials
- Phase 44 trials
- Status
- Recruiting105 trials
- Active, not recruiting94 trials
- Completed62 trials
- Not yet recruiting24 trials
- Suspended2 trials
- Lead sponsor
- Novartis Pharmaceuticals15 trials
- AstraZeneca14 trials
- Janssen Research & Development, LLC13 trials
- Amgen10 trials
- AbbVie9 trials
- and 122 more
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A phase II trial of CY-101 in participants with adrenocortical cancer.
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
The RAPID-Elapse study: Can the drug bupropion improve fatigue symptoms in patients with long COVID?
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Recruiting
A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Showing 50 of 223.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers20 recruiting
- Multiple myeloma20 recruiting
- Lung cancer15 recruiting
- Acute lymphoblastic leukaemia8 recruiting
- Follicular lymphoma5 recruiting
- Pancreatic cancer5 recruiting
- Chronic lymphocytic leukaemia4 recruiting
- Myasthenia gravis4 recruiting
- Stroke4 recruiting
- Amyloidosis3 recruiting
- Fatty liver disease (MASLD/MASH)3 recruiting
- Hodgkin lymphoma3 recruiting
- Liver and biliary tract cancer3 recruiting
- Macular degeneration3 recruiting
- Mantle cell lymphoma3 recruiting
- Melanoma3 recruiting
- Obesity3 recruiting
- Prostate cancer3 recruiting
- Colorectal cancer2 recruiting
- Graves' disease2 recruiting
- Heart failure2 recruiting
- Ovarian cancer2 recruiting
- Parkinson disease2 recruiting
- Atrial fibrillation1 recruiting
- Chronic kidney disease1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Coronary artery disease1 recruiting
- Cushing's syndrome1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Fabry disease1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Hepatitis B1 recruiting
- Hidradenitis suppurativa1 recruiting
- Huntington's disease1 recruiting
- Hypertrophic cardiomyopathy1 recruiting
- Kidney cancer1 recruiting
- Lichen planus1 recruiting
- Liver cirrhosis1 recruiting
- Long COVID and ME/CFS1 recruiting
- Lupus (SLE)1 recruiting
- Multiple sclerosis1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Neuroblastoma1 recruiting
- Neuroendocrine tumours1 recruiting
- Psoriasis1 recruiting
- Sarcoidosis1 recruiting
- Sarcoma1 recruiting
- Sjögren's disease1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Type 1 diabetes1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Active, not recruiting
Completed
Completed
Active, not recruiting
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
Active, not recruiting
Active, not recruiting
A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)
Active, not recruiting
A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Completed
Completed
CABONEN – a phase II trial of Cabozantinib in patients with advanced, low proliferative NEN G3
Completed
Completed
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Terminated
Prednisolone Versus Colchicine for Acute Gout in Primary Care
Completed
Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Terminated
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Terminated
Completed
Completed
Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping
Completed
Phase 1 Study of UniCAR02-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies
Completed
Completed
Active, not recruiting
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
Completed
Completed
Showing 50 of 62.
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026